Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Should we lower cholesterol as much as possible?

Ravnskov U, Rosch PJ, Sutter MC, Houston MC.

BMJ. 2006 Jun 3;332(7553):1330-2. Review. No abstract available.

2.

Rhabdomyolysis in heart transplant patients on HMG-CoA reductase inhibitors and cyclosporine.

Rodríguez JA, Crespo-Leiro MG, Paniagua MJ, Cuenca JJ, Hermida LF, Juffé A, Castro-Beiras A.

Transplant Proc. 1999 Sep;31(6):2522-3. No abstract available.

PMID:
10500698
3.

Prescribing statins: the real issues.

Hamilton-Craig IR.

Med J Aust. 2014 May 5;200(8):440-1. No abstract available.

PMID:
24794593
4.

Should we lower cholesterol as much as possible? Cholesterol is good?

de Wolff JF.

BMJ. 2006 Jun 17;332(7555):1453. No abstract available.

5.

[Transplant coronary artery disease--treatment with statins].

Wolszakiewicz J, Bilińska M.

Pol Merkur Lekarski. 2004 May;16(95):472-3. Review. Polish.

PMID:
15518430
6.
7.

Means and ends of statins and low-density lipoprotein cholesterol lowering.

LaRosa JC.

J Am Coll Cardiol. 2007 Jul 31;50(5):419-20. Epub 2007 Jul 16. No abstract available.

8.

Low-density lipoprotein reduction and cancer: not definitive but provocative.

DeMaria AN, Ben-Yehuda O.

J Am Coll Cardiol. 2007 Jul 31;50(5):421-2. Epub 2007 Jul 16. No abstract available.

9.

The cholesterol paradox in heart failure.

Velavan P, Huan Loh P, Clark A, Cleland JG.

Congest Heart Fail. 2007 Nov-Dec;13(6):336-41. Review.

10.
11.

Other reports of cerivastatin-induced rhabdomyolysis.

Gabay M, Lodolce A.

Arch Intern Med. 2001 Nov 26;161(21):2629. No abstract available.

PMID:
11718614
12.

Case reports of rhabdomyolysis associated with cerivastatin therapy.

Simpson S.

Arch Intern Med. 2001 Nov 26;161(21):2630-1. No abstract available.

PMID:
11718617
13.

Another report of acute rhabdomyolysis following cerivastatin monotherapy.

Milionis HJ, Tsapoga TG, Elisaf MS.

Arch Intern Med. 2001 Nov 26;161(21):2629-30. No abstract available.

PMID:
11718615
14.

The cardiology patient page. Statins: powerful drugs for lowering cholesterol: advice for patients.

Gotto AM Jr.

Circulation. 2002 Apr 2;105(13):1514-6. No abstract available.

15.

The influence of statin characteristics on their safety and tolerability.

De Angelis G.

Int J Clin Pract. 2004 Oct;58(10):945-55. Review.

PMID:
15587774
16.

Risperidone and severe cerivastatin-induced rhabdomyolysis.

Giner V, Muñoz R, Redón J.

J Intern Med. 2002 Feb;251(2):177-8. No abstract available.

17.

Fluvastatin: efficacy and safety in reducing cardiac events.

Chan MY, Lee CH.

Expert Opin Pharmacother. 2005 Sep;6(11):1883-95. Review.

PMID:
16144508
18.

Myotonic potentials in statin-induced rhabdomyolysis.

de Almeida DF, Lissa TV, Melo AC Jr.

Arq Neuropsiquiatr. 2008 Dec;66(4):891-3. No abstract available.

19.

Simvastatin-induced rhabdomyolysis.

Ho MR, Baker JE, Miller AL.

Am J Emerg Med. 2004 May;22(3):234-5. No abstract available.

PMID:
15138970
20.

[A comparative long-term trial of sodium cerivastatin, a new HMG-CoA reductase inhibitor, in patients presenting with primary hypercholesterolemia].

Sasaki J, Arakawa K, Yamamoto K, Kobori S, Ageta M, Kono S.

Rev Med Interne. 1999 Aug;20 Suppl 3:393s-398s. French.

PMID:
10480191
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk